(Q37135229)

18 August 2017

Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy (English)

1 reference

18 August 2017

1 reference

2

A Fosså

1 reference

18 August 2017

6

S D Fosså

1 reference

18 August 2017

4

H Holte

1 reference

18 August 2017

C E Kiserud

1

1 reference

18 August 2017

T Bjøro

series ordinal

3

1 reference

18 August 2017

M Cvancarova

series ordinal

5

1 reference

18 August 2017

language of work or name

English

0 references

publication date

20 January 2009

1 reference

British Journal of Cancer

18 August 2017

1 reference

18 August 2017

100

1 reference

18 August 2017

3

1 reference

18 August 2017

455-463

1 reference

Post-treatment parenthood in Hodgkin's lymphoma survivors

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658535

American Society of Clinical Oncology recommendations on fertility preservation in cancer patients

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658535

Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658535

Testicular function following chemotherapy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658535

Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658535

Prevalence of symptomatic androgen deficiency in men.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658535

Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate, etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patients

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658535

MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658535

Mitoxantrone, etoposide, cytarabine and prednisone as salvage therapy for refractory non-Hodgkin lymphoma (NHL) and alternated with CHOP in previously untreated patients with NHL.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658535

Testicular dysfunction in Hodgkin's disease before and after treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658535

Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658535

Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658535

Changes in BMI after treatment of testicular cancer are due to age and hormonal function and not chemotherapy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658535

Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658535

The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromsø Study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658535

High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658535

Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658535

Semen analysis and cryoconservation before treatment in Hodgkin's disease.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658535

ChlVPP is as effective as alternating ChlVPP/ABOD in advanced stage Hodgkin's disease

3 September 2018

1 reference

12 December 2020

Sperm quality in Hodgkin's disease versus non-Hodgkin's lymphoma

1 reference

12 December 2020

Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adult

1 reference

12 December 2020

The impact of mild Leydig cell dysfunction following cytotoxic chemotherapy on bone mineral density (BMD) and body composition

1 reference

12 December 2020

Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis

1 reference

12 December 2020

High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Bl

1 reference

12 December 2020

Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment

1 reference

12 December 2020

CD34(+) cell enrichment depletes atypical CD30(+) cells from PBPC grafts in patients with HD

1 reference

12 December 2020

The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male

1 reference

12 December 2020

Osteoporosis in men with idiopathic hypogonadotropic hypogonadism

1 reference

12 December 2020

Estimated 8-year survival of more than 40% in a population-based study of 79 adult patients with acute lymphoblastic leukaemia

1 reference

12 December 2020

Clinical stage I and II Hodgkin's disease: long-term results of therapy without laparotomy. Experience at one institution

1 reference

12 December 2020

Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6604892

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19156143

1 reference